APA (7th ed.) Citation

Wang, H., Yeh, T., Chan, L., Hsu, C., & Cho, S. (2020). Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice. International journal of molecular sciences, 21(20), 7621. https://doi.org/10.3390/ijms21207621

Chicago Style (17th ed.) Citation

Wang, Hui-Ching, Tsung-Jang Yeh, Leong-Perng Chan, Chin-Mu Hsu, and Shih-Feng Cho. "Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice." International Journal of Molecular Sciences 21, no. 20 (2020): 7621. https://doi.org/10.3390/ijms21207621.

MLA (9th ed.) Citation

Wang, Hui-Ching, et al. "Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice." International Journal of Molecular Sciences, vol. 21, no. 20, 2020, p. 7621, https://doi.org/10.3390/ijms21207621.